Show Notes
Most conversations about “AI in Medicine” bore me. I think this is because either we lack the imagination to consider how AI will change medicine in the next decade, or we are not being specific enough about how small parts of medicine could be productively affected. Dr. Shantanu Nundy, MD, MBA, is a practicing physician whom I like to think of as a serial innovator. He is currently an advisor on artificial intelligence to the FDA in the Commissioner’s Office. He has spent a great deal of time and energy thinking deeply about what AI can bring us today and in the future. I hope you enjoy this conversation.
This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe
More from Sensible Medicine
Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults Catheter ablation for symptomatic atrial fibrillation (PVI-SHAM-AF): a randomised, double-blind, sham-controlled, multicentre trial * This Week in Cardiology with John M. Mandrola MD * Cardiology Trials And a special treat/rescouce we have covered nearly 100 articles at this point on the podcast. Here is an active list of all the articles we have discussed. Take a look, read the articles, and refer to our conversation if you wish!
This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe
Colorectal Cancer and Mortality Risk Among Older Adults With vs Without Adenoma on Prior Colonoscopy * The Hubris of Screening for Disease — Again Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment * Why Blood Tests Are a Poor Screening Tool for Alzheimer’s
Cancer-Related Mortality Among US Pilots and Flight Attendants Response-Tailored or Standard-Duration Antibiotic Treatment for Infective Endocarditis